ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0066

RA-required synovial tissue-resident monocyte lineage cells are comprised of three distinct subpopulations.

Yidan Wang1, Samuel Dowling2, Jessica Maciuch2, Vanessa Manada De Lobos2, Meghan Mayer2, Kainat Mian1, Tyler Therron3, Hadijat Makinde1, Carla Marie Cuda1, Deborah Rachelle Winter4 and Harris R Perlman1, 1Northwestern University, Chicago, IL, 2Northwestern University, Chicago, 3Northwestern Feinberg School of Medicine, Chicago, IL, 4Northwestern University, Skokie, IL

Meeting: ACR Convergence 2025

Keywords: Experimental Arthritis, Inflammation, Monocytes/macrophages, Mouse Models, RA, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0049–0066) Rheumatoid Arthritis – Animal Models Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Tissue-resident monocyte-lineage cell (TRMC) are an extravascular population distinct from circulating monocytes and synovial macrophages and are critical for the development of inflammatory arthritis. Previous fate-mapping results demonstrated that TRMC are at least partially derived from the fetal liver and are traceable using various myeloid-related fate-mapping models, suggesting potential heterogeneity within this population. However, the precise identities and origins of TRMC subpopulations remain unclear.

Methods: We first measured the long-lived and bone marrow (BM)-derived TRMC in bone marrow chimeras (BMC) and parabiosis mice. Next, we used single-cell RNA-sequencing with surface marker detection (CITE-seq) to investigate the heterogeneity of TRMC during homeostasis and their dynamic changes after the synovial disruption induced by clodronate-laden liposome (Clo. Lip) and throughout the progression of RA-like disease in mice. To investigate the dependence of TRMC subpopulations on Ccr2, we utilized BMC and parabiosis mice models between CD45.1 B6 and Ccr2-/- mice.

Results: We characterized the ontogeny of TRMC, which comprises both bone-marrow (BM)-derived and long-lived populations. Furthermore, CITE-seq identified three TRMC subpopulations, distinguished by TIM4, CX3CR1, and MHCII surface marker expression, each exhibiting distinct functions. TIM4+CX3CR1+ TRMC were enriched for pathways involved in synovial hemostasis, whereas MHCII+ TRMC were more enriched for inflammatory response pathways, with TIM4+ TRMC exhibiting functional features of both. Clo. Lip modestly reduced the absolute number of TRMC but did not impact proportions or transcriptional profile of TRMC at 7 days post administration. Under steady state, TIM4+CX3CR1+ and TIM4+ TRMC represented the long-lived population, whereas MHCII+ TRMC were BM-derived and dependent on Ccr2. During synovial inflammation, BM-derived TRMC expanded up to threefold at the peak of arthritis compared to baseline and replenished the TIM4+CX3CR1+ and TIM4+ TRMC compartments. Additionally, TIM4+ TRMC underwent transcriptional and functional changes resembling MHCII+ TRMC during the peak and plateau stages of RA-like arthritis in mice.

Conclusion: These findings underscore the heterogeneity within TRMC and highlight their distinct responses to synovial disruption and potential roles in rheumatoid arthritis (RA). Future therapeutic target strategies should focus on TRMC by targeting their specific subpopulations.


Disclosures: Y. Wang: None; S. Dowling: None; J. Maciuch: None; V. Manada De Lobos: None; M. Mayer: None; K. Mian: None; T. Therron: None; H. Makinde: None; C. Cuda: None; D. Winter: None; H. Perlman: AbbVie/Abbott, 2.

To cite this abstract in AMA style:

Wang Y, Dowling S, Maciuch J, Manada De Lobos V, Mayer M, Mian K, Therron T, Makinde H, Cuda C, Winter D, Perlman H. RA-required synovial tissue-resident monocyte lineage cells are comprised of three distinct subpopulations. [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/ra-required-synovial-tissue-resident-monocyte-lineage-cells-are-comprised-of-three-distinct-subpopulations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ra-required-synovial-tissue-resident-monocyte-lineage-cells-are-comprised-of-three-distinct-subpopulations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology